|
|
Volumn 7, Issue 4, 2003, Pages 468-472
|
|
The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIARRHYTHMIC AGENT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DEFIBRILLATOR;
EQUIPMENT DESIGN;
HEART ARRHYTHMIA;
HEART LEFT VENTRICLE FUNCTION;
HEART PACING;
HEART STROKE VOLUME;
HEART VENTRICLE;
HEART VENTRICLE TACHYCARDIA;
HUMAN;
METHODOLOGY;
PATHOPHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
ANTI-ARRHYTHMIA AGENTS;
ARRHYTHMIA;
CARDIAC PACING, ARTIFICIAL;
DEFIBRILLATORS, IMPLANTABLE;
EQUIPMENT DESIGN;
HEART VENTRICLES;
HUMANS;
RANDOMIZED CONTROLLED TRIALS;
RESEARCH DESIGN;
STROKE VOLUME;
TACHYCARDIA, VENTRICULAR;
VENTRICULAR DYSFUNCTION, LEFT;
|
|
EID: 4143060127
PISSN: 13852264
EISSN: None
Source Type: Journal
DOI: 10.1023/B:CEPR.0000023165.20987.b1 Document Type: Article |
|
Times cited : (48)
|
|
References (0)
|
